血清微小RNA-26a、微小RNA-34a联合预测子宫肌瘤患者单孔腹腔镜术后复发的价值OA
Value of combined prediction of serum microRNA-26a and microRNA-34a in predicting recurrence of patients with uterine fibroids after single-port laparoscopy
目的 分析子宫肌瘤(UF)患者单孔腹腔镜手术前后血清微小RNA-26a(miR-26a)、微小RNA-34a(miR-34a)水平变化及其联合预测术后复发的价值.方法 选取行单孔腹腔镜手术的UF患者200例作为研究组,另选取同期体检健康女性100例作为对照组.比较2组的血清miR-26a、miR-34a水平.研究组术后均随访1年,统计术后复发情况.比较复发患者与未复发患者的一般资料以及术前、术后第3个月的血清miR-26a、miR-34a水平及变化值(以△表示术前与术后第3个月水平差值的绝对值),并筛选术后复发的影响因素.分析△ miR-26a、△miR-34a预测UF患者术后复发的价值.结果 研究组术前血清miR-26a、miR-34a水平低于对照组,差异有统计学意义(P<0.05).研究组患者术后随访期间失访5例,最终有195例患者完成随访,其中51例患者复发,复发率为26.15%(51/195).复发患者的UF数目多于未复发患者,UF最大径大于未复发患者,术后24 h血清糖类抗原-199(CA-199)、癌胚抗原(CEA)水平高于未复发患者,差异有统计学意义(P<0.05).术后第3个月,研究组复发患者与未复发患者的血清miR-26a、miR-34a水平高于术前,差异有统计学意义(P<0.05).复发患者术前、术后第3个月的血清miR-26a、miR-34a水平及△miR-26a、△miR-34a低于未复发患者,差异有统计学意义(P<0.05).UF数目、术后24 h血清CA-199、CEA水平、△miR-26a、△miR-34a均为UF患者术后复发的影响因素(P<0.05).△miR-26a联合△miR-34a预测术后复发的曲线下面积(AUC)为0.847,大于△ miR-26a、△miR-34a、UF数目、术后24 h血清CA-199、CEA单独预测的AUC(P<0.05).结论 UF患者的血清miR-26a、miR-34a水平显著降低,且其手术前后变化值与术后复发密切相关,△miR-26a、△miR-34a联合预测术后复发的效能显著优于传统肿瘤标志物.
Objective To analyze the changes in serum levels of microRNA-26a(miR-26a)and microRNA-34a(miR-34a)before and after single-port laparoscopic surgery for uterine fibroids(UF),as well as the value of their combined use in predicting postoperative recurrence.Methods A total of 200 UF patients who underwent single-port laparoscopic surgery were selected as study group,and 100 healthy women who underwent physical examinations during the same period were selected as control group.The serum levels of miR-26a and miR-34a were compared between the two groups.All patients in the study group were followed up for 1 year after surgery,and the postoperative recurrence status was recorded.The general information,as well as the preoperative and postoperative(at the 3rd month)serum miR-26a and miR-34a levels and their changes(denoted by △,representing the absolute difference value between preoperative and the 3rd postoperative month)were compared be-tween recurrent and non-recurrent patients,and the influencing factors for postoperative recurrence were screened.The value of △miR-26a and △miR-34a in predicting postoperative recurrence in UF patients was analyzed.Results The preoperative serum miR-26a and miR-34a levels in the study group were significantly lower than those in the control group(P<0.05).In the study group,5 were lost to follow-up during the postoperative follow-up period,ultimately,195 patients completed the follow-up,of whom 51 patients experienced recurrence,with a recurrence rate of 26.15%(51/195).The number of UF in recurrent patients was significantly higher,the maximum diameter of UF was significantly larger,and the serum carbohydrate antigen-199(CA-199)and carcinoembryonic anti-gen(CEA)levels at 24 hours postoperatively were significantly higher in recurrent patients than those in non-recurrent patients(P<0.05).At the 3rd month postoperatively,the serum miR-26a and miR-34a levels in both recurrent and non-recurrent patients in the study group were significantly higher than those preoperatively(P<0.05).The preoperative and postoperative(at the 3 rd month)serum miR-26a and miR-34a levels,as well as △miR-26a and △miR-34a were significant-ly lower in recurrent patients than those in non-recurrent patients(P<0.05).The number of UF,serum CA-199 and CEA levels at 24 hours postoperatively,△miR-26a and △miR-34a were all in-fluencing factors for postoperative recurrence in UF patients(P<0.05).The area under the curve(AUC)for predicting postoperative recurrence using the combination of △miR-26a and △miR-34a was 0.847,which was greater than the AUCs for predicting recurrence using △miR-26a,△miR-34a,the number of UFs as well as serum CA-199 and CEA levels at 24 hours postoperatively alone(P<0.05).Conclusion The serum miR-26a and miR-34a levels are significantly decreased in UF pa-tients,and their changes before and after surgery are closely related to postoperative recurrence.The combined predictive efficacy of △miR-26a and △miR-34a for postoperative recurrence is signifi-cantly superior to that of traditional tumor markers.
程萍;魏君子;孔梅
乌鲁木齐市妇幼保健院/乌鲁木齐市友爱医院 妇科,新疆乌鲁木齐,830000乌鲁木齐市妇幼保健院/乌鲁木齐市友爱医院 妇科,新疆乌鲁木齐,830000乌鲁木齐市妇幼保健院/乌鲁木齐市友爱医院 妇科,新疆乌鲁木齐,830000
医药卫生
子宫肌瘤单孔腹腔镜微小RNA-26a微小RNA-34a术后复发癌胚抗原影响因素预测效能
uterine fibroidssingle-port laparoscopymicroRNA-26amicroRNA-34apostop-erative recurrencecarcinoembryonic antigeninfluencing factorspredictive efficacy
《实用临床医药杂志》 2026 (4)
115-120,6
新疆维吾尔自治区自然科学基金资助项目(2020D01C1012)
评论